Goldman Sachs’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.56M | Sell |
153,171
-27,692
| -15% | -$299K | ﹤0.01% | 4747 |
|
|
2025
Q4 | $1.93M | Sell |
180,863
-30,555
| -14% | -$366K | ﹤0.01% | 4618 |
|
|
2025
Q3 | $2.89M | Buy |
211,418
+54,702
| +35% | +$764K | ﹤0.01% | 4149 |
|
|
2025
Q2 | $2.2M | Sell |
156,716
-15,522
| -9% | -$204K | ﹤0.01% | 4101 |
|
|
2025
Q1 | $2.32M | Sell |
172,238
-180,767
| -51% | -$2.71M | ﹤0.01% | 4024 |
|
|
2024
Q4 | $6.22M | Buy |
353,005
+67,174
| +24% | +$1.25M | ﹤0.01% | 3231 |
|
|
2024
Q3 | $5.47M | Buy |
285,831
+115,265
| +68% | +$2.22M | ﹤0.01% | 3262 |
|
|
2024
Q2 | $3.72M | Buy |
170,566
+96,832
| +131% | +$2.58M | ﹤0.01% | 3428 |
|
|
2024
Q1 | $2.83M | Buy |
73,734
+36,110
| +96% | +$1.75M | ﹤0.01% | 3593 |
|
|
2023
Q4 | $2.53M | Buy |
37,624
+15,713
| +72% | +$1.09M | ﹤0.01% | 3744 |
|
|
2023
Q3 | $1.64M | Sell |
21,911
-14,603
| -40% | -$1.3M | ﹤0.01% | 3923 |
|
|
2023
Q2 | $3.37M | Buy |
36,514
+1,588
| +5% | +$141K | ﹤0.01% | 3446 |
|
|
2023
Q1 | $3.62M | Buy |
34,926
+3,262
| +10% | +$362K | ﹤0.01% | 3359 |
|
|
2022
Q4 | $3.65M | Buy |
31,664
+12,481
| +65% | +$1.45M | ﹤0.01% | 3454 |
|
|
2022
Q3 | $2.08M | Sell |
19,183
-2,899
| -13% | -$415K | ﹤0.01% | 3939 |
|
|
2022
Q2 | $3.99M | Sell |
22,082
-4,929
| -18% | -$882K | ﹤0.01% | 3370 |
|
|
2022
Q1 | $4.61M | Buy |
27,011
+10,167
| +60% | +$1.92M | ﹤0.01% | 3430 |
|
|
2021
Q4 | $3.53M | Sell |
16,844
-31,009
| -65% | -$6.41M | ﹤0.01% | 3745 |
|
|
2021
Q3 | $9.22M | Buy |
47,853
+29,319
| +158% | +$7.21M | ﹤0.01% | 2812 |
|
|
2021
Q2 | $5.25M | Sell |
18,534
-24,766
| -57% | -$6.71M | ﹤0.01% | 3294 |
|
|
2021
Q1 | $9.17M | Sell |
43,300
-6,510
| -13% | -$1.56M | ﹤0.01% | 2645 |
|
|
2020
Q4 | $9.78M | Buy |
49,810
+9,686
| +24% | +$1.71M | ﹤0.01% | 2487 |
|
|
2020
Q3 | $6.6M | Sell |
40,124
-104,324
| -72% | -$17.2M | ﹤0.01% | 2681 |
|
|
2020
Q2 | $20M | Sell |
144,448
-10,262
| -7% | -$942K | 0.01% | 1687 |
|
|
2020
Q1 | $9.67M | Buy |
154,710
+17,576
| +13% | +$1.6M | ﹤0.01% | 2111 |
|
|
2019
Q4 | $15M | Buy |
137,134
+58,343
| +74% | +$5.65M | ﹤0.01% | 2096 |
|
|
2019
Q3 | $8.16M | Buy |
78,791
+63,183
| +405% | +$6.79M | ﹤0.01% | 2480 |
|
|
2019
Q2 | $2M | Sell |
15,608
-41,405
| -73% | -$5.75M | ﹤0.01% | 3559 |
|
|
2019
Q1 | $7.27M | Sell |
57,013
-127,176
| -69% | -$16.1M | ﹤0.01% | 2686 |
|
|
2018
Q4 | $23M | Sell |
184,189
-69,122
| -27% | -$11.8M | 0.01% | 1698 |
|
|
2018
Q3 | $56.1M | Buy |
253,311
+91,793
| +57% | +$18.6M | 0.01% | 1147 |
|
|
2018
Q2 | $25.9M | Buy |
161,518
+76,958
| +91% | +$9.84M | 0.01% | 1696 |
|
|
2018
Q1 | $7.9M | Buy |
84,560
+2,544
| +3% | +$190K | ﹤0.01% | 2535 |
|
|
2017
Q4 | $5.72M | Buy |
82,016
+26,958
| +49% | +$1.79M | ﹤0.01% | 2904 |
|
|
2017
Q3 | $3.27M | Sell |
55,058
-34,548
| -39% | -$1.72M | ﹤0.01% | 3537 |
|
|
2017
Q2 | $3.72M | Buy |
89,606
+59,437
| +197% | +$2.58M | ﹤0.01% | 3303 |
|
|
2017
Q1 | $1.34M | Sell |
30,169
-15,964
| -35% | -$687K | ﹤0.01% | 4122 |
|
|
2016
Q4 | $1.92M | Buy |
46,133
+6,250
| +16% | +$252K | ﹤0.01% | 3890 |
|
|
2016
Q3 | $1.51M | Sell |
39,883
-48,699
| -55% | -$1.75M | ﹤0.01% | 4051 |
|
|
2016
Q2 | $2.95M | Sell |
88,582
-3,046
| -3% | -$98.3K | ﹤0.01% | 3283 |
|
|
2016
Q1 | $2.77M | Buy |
91,628
+7,638
| +9% | +$223K | ﹤0.01% | 3202 |
|
|
2015
Q4 | $2.55M | Sell |
83,990
-20,327
| -19% | -$605K | ﹤0.01% | 3426 |
|
|
2015
Q3 | $2.8M | Buy |
104,317
+16,787
| +19% | +$489K | ﹤0.01% | 3439 |
|
|
2015
Q2 | $2.83M | Buy |
87,530
+6,314
| +8% | +$200K | ﹤0.01% | 3496 |
|
|
2015
Q1 | $2.43M | Sell |
81,216
-2,957
| -4% | -$93.9K | ﹤0.01% | 3584 |
|
|
2014
Q4 | $2.82M | Buy |
84,173
+77,039
| +1,080% | +$2.4M | ﹤0.01% | 3512 |
|
|
2014
Q3 | $234K | Sell |
7,134
-4,874
| -41% | -$150K | ﹤0.01% | 6013 |
|
|
2014
Q2 | $365K | Sell |
12,008
-21,174
| -64% | -$660K | ﹤0.01% | 5603 |
|
|
2014
Q1 | $965K | Sell |
33,182
-17,940
| -35% | -$481K | ﹤0.01% | 4704 |
|
|
2013
Q4 | $1.34M | Buy |
51,122
+4,405
| +9% | +$113K | ﹤0.01% | 4481 |
|
|
2013
Q3 | $1.26M | Buy |
46,717
+24,002
| +106% | +$642K | ﹤0.01% | 4389 |
|
|
2013
Q2 | $585K | Buy |
+22,715
| New | +$597K | ﹤0.01% | 4804 |
|
Other funds holding MED
SCP
VCM
Goldman Sachs's MED Position: Q1 2026 in Review
Goldman Sachs reduced its Medifast (MED) stake by 15% in Q1 2026, selling an estimated $299K and leaving 153,171 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4747.
Goldman Sachs first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $56.1M in Q3 2018. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.
- Goldman Sachs held 153,171 shares of Medifast worth $1.56M as of Q1 2026.
- Goldman Sachs sold 27,692 Medifast shares in Q1 2026, an estimated $299K.
- Medifast made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4747 holding.
- Goldman Sachs first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Medifast position peaked at $56.1M in Q3 2018.
- 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.